Delivery Order 36C25022D0006-36C25025F0011

Award Date 10/1/24
Potential Completion Date 9/30/26
Potential Value $1.6M
Awardee
Sofie CO.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of radioactive isotopes and PET tracers. The contract has a ceiling value of $339,600.00 and a period of performance through February 28, 2026. This Delivery Order is issued under a larger Indefinite Delivery Vehicle (IDV) contract with the VA VISN 17 network, which facilitates the ongoing procurement of Sofie's specialized radiopharmaceuticals and related services to...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO., a for-profit manufacturer of molecular diagnostics and therapeutics. The contract, which does not have a set-aside designation, is for the period of October 1, 2019 to September 30, 2020 and has a potential value of $1,906,156.25. Sofie CO. is the prime contractor and a subsidiary of Sofie Biosciences, Inc. The contract provides the VA with PET imaging agents,...
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
This federal contract award, with ID 36C25022D0006|36C25024N0047, is for exercising Ordering Period 3 from October 1, 2023, to September 30, 2024, with a ceiling value of $1,344,854.56. The contract was awarded to Sofie CO., doing business as Sofie, which is a subsidiary of Sofie Biosciences, Inc. Sofie is a specialized supplier of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the Department of Veterans Affairs (VA), Defense Health Agency...
This is a federal contract award to Sofie CO., doing business as Sofie, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1). The contract is for the supply of radiopharmaceuticals, valued at $173,674.50, to support medical imaging and cancer treatment programs for veterans. The contract has a firm fixed price and runs from April 1, 2016, to September 30, 2017. There was no set-aside designation used for this award. In addition to this contract, Sofie holds...
This is a Delivery Order contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, for the supply of a radiopharmaceutical needed for the treatment of prostate cancer patients with metastatic lesions. The contract has a ceiling value of $10,826.16 and a completion date of September 30, 2024. Sofie is a subsidiary of Sofie Biosciences, Inc., specializing in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals,...
This is a delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Sofie CO. for the supply of PET imaging agents and related services over a one-year period from October 2021 to September 2022. The potential value of the contract is $147,415.50. Sofie CO. is the prime contractor and is a for-profit organization that specializes in the development and delivery of molecular diagnostics and therapeutics. The contract does not have a set-aside...
This is a Delivery Order awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The Delivery Order is for the FY20 delivery of PET radiopharmaceuticals to the VA Western NY Healthcare System Nuclear Medicine Department. The contract has a ceiling value of $83,538.00 and a completion date of February 28, 2021. The contract is a Firm Fixed Price Delivery Order and was not set aside. Sofie CO. is a specialized manufacturer and supplier of...
This is a delivery order awarded to Sofie CO., a for-profit organization, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 15. The order, valued at $177,633.50, is for the supply of PET imaging agents to VA facilities from October 1, 2018 to September 30, 2019. Sofie CO. is an experienced federal contractor that provides radiopharmaceuticals, pharmaceuticals, and related services to the VA, Defense Health Agency, and National...
  • 36C25022D0006
    Indefinite Delivery Contract
  • 36C25022D0006-36C25025F0011
    Delivery Order

This is a delivery order awarded to Sofie CO., doing business as Sofie, by the Department of Veterans Affairs (VA) under a larger Indefinite Delivery Vehicle (IDV) contract. The contract, valued at $1,600,086.72, is for the ordering period 4 of option year 25, with a completion date of September 30, 2026.

Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals, for federal agencies including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH). This contract supports Sofie's ongoing supply of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to VA hospitals and military treatment facilities. The contract does not have a set-aside designation, reflecting Sofie's established position as a specialized supplier in this field. Sofie also holds several other significant IDV contracts with the VA and DHA for the continued provision of its radiopharmaceutical products and related services.

Generated 10/2/24, 10:25 AM